EUVIMEDEUVIMED entdecken
Crossref

Structure-guided design of icaritin-based scaffold modifications for enhanced osteoporotic therapy

Rui-Yue Liu, Ze-Kun Chen, Hui-Ru Liu, Zhou Xu, Ming Yu, Cheng-Chen Hou, Li-Wen Han, Kui Lu, Ke-Wu Zeng

Bioorganic Chemistry · 2026-07 · 175 · 109794

DOI: 10.1016/j.bioorg.2026.109794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-07. Verfasst von Rui-Yue Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin Unive…. Hauptthemen laut MEDLINE: Flavonoids, Osteoporosis, Drug Design. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Icaritin, a flavonoid compound, has been shown to alleviate osteoporosis by promoting the differentiation of osteoblasts. However, research on the structural modification and optimization of icaritin has been limited. To enhance the anti-osteoporotic efficacy of icaritin, we structurally modified the compound by substituting the hydroxyl groups, resulting in the synthesis of 22 derivatives. The impact of these compounds was examined by evaluating Human embryonic palatal mesenchymal (HEPM) cells viability with the MTT assay, along with assessing osteogenic potential through measurement of alkaline phosphatase (ALP) activity. In vivo validation of anti-osteoporotic activity was conducted using a prednisolone induced zebrafish model. The results indicated that compound 8a exhibited significant osteogenic activity. Structure-activity relationship analysis revealed that 7-OH esterification substantially potentiated osteogenic activity without eliciting cytotoxic effects in HEPM cells. However, modifications at the 3-OH and 5-OH positions enhanced cytotoxicity while diminishing osteogenic activity. Collectively, our findings characterize icaritin derivatives exhibiting enhanced osteogenic efficacy through improved osteoblast differentiation and present a promising compound for development of anti-osteoporotic drug candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsOsteoporosisDrug DesignStructure-Activity RelationshipHumansZebrafishAnimalsMolecular StructureOsteogenesisCell SurvivalOsteoblastsCell DifferentiationDose-Response Relationship, DrugMesenchymal Stem CellsCells, Cultured

Stichwörter der Autor:innen

Anti-osteoporosisFlavonoid compoundIcaritinOsteoblastsStructure-activity relationship

Substanzen

icaritinFlavonoids

Autor:innen und Institutionen

  • China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &Technology, Tianjin 300457, China; State Key Laborat…
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Department of Integration of Chinese and Western Medicine, School of Basic Medical Scien…
  • National Key Laboratory of Advanced Drug Delivery and Release Systems, School of Pharmaceutical Sciences & Institute of Materia Medica, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250…
  • State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
  • China International Science and Technology Cooperation Base of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science &Technology, Tianjin 300457, China. Electronic addres…

Förderung

  • Science and Technology Program of Guizhou Province

Zitieren

APA

Liu, R. Y., Chen, Z. K., Liu, H. R., Xu, Z., Yu, M., Hou, C. C., Han, L. W., Lu, K., & Zeng, K. W. (2026). Structure-guided design of icaritin-based scaffold modifications for enhanced osteoporotic therapy. Bioorganic Chemistry, 175, 109794. https://doi.org/10.1016/j.bioorg.2026.109794

Vancouver

Liu RY, Chen ZK, Liu HR, Xu Z, Yu M, Hou CC, et al. Structure-guided design of icaritin-based scaffold modifications for enhanced osteoporotic therapy. Bioorganic Chemistry. 2026;175:109794. doi:10.1016/j.bioorg.2026.109794

BibTeX
@article{Liu2026,
  author = {Liu, Rui-Yue and Chen, Ze-Kun and Liu, Hui-Ru and Xu, Zhou and Yu, Ming and Hou, Cheng-Chen and Han, Li-Wen and Lu, Kui and Zeng, Ke-Wu},
  title = {Structure-guided design of icaritin-based scaffold modifications for enhanced osteoporotic therapy},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {175},
  pages = {109794},
  doi = {10.1016/j.bioorg.2026.109794}
}
Kostenlos starten →